July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study – EORTC
Jul 10, 2025, 20:44

We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study – EORTC

EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:

“We’re excited to announce that the first patient has been randomised in the PROLoNG study!

The patient was enrolled at Hospital Universitari Vall d’Hebron, under the supervision of Principal Investigator Irene Braña.

The EORTC-2014 PROLoNg study focuses on Pembrolizumab and Radiotherapy for OLigometastatic squamous cell carcinoma of the head and Neck: a randomised phase III study.

Two Spanish sites are currently active in this international trial, with more to follow soon.
Learn more.

The PROLoNg study is supported by MSD,

Spanish Association Against Cancer, EORTC Cancer Research Fund, and Belgian Foundation Against Cancer.”

More posts featuring EORTC.